Marcella Rogers

Experience

• 

  IPA Management Consultants

  Jan 2003 - Jan 2005

  Sr. Business Analyst (Consultant)

  Conducted on-site quantitative and qualitative business analysis of over 150 small to medium size businesses throughout the US and Canada. Highlighted critical findings and made recommendations for improvement to executive management and/or BOD.

• 

  Covance

  Jan 2005 - Jan 2012

  Associate Finance Director, Global Early Development & Progressive Financial Analyst Roles

  Led operating and strategic planning; annual and quarterly budgeting and forecasting; capital investing and divestitures; pricing strategies. Progressive Roles Included: Associate Finance Director, Global Early Development | Lead Strategic Financial Analyst, Global Analytical Services | Senior Financial Analyst, Global Support Groups & Analytical Services | Financial Analyst, Support Groups

• 

  Lexicon Pharmaceuticals, Inc.

  Jan 2013 - Jan 2018

  Senior Director, R&D Program & Alliance Management / Director, CRO Management

  Provided R&D program leadership for cross-functional planning, execution, and management of integrated portfolio timelines across vendor and pharmaceutical partnerships. Drove clinical operations, including developing and mentoring clinical project managers. Previously established, negotiated, and optimized external vendor partnerships in executing nonclinical studies, phase I–III clinical trains and ISE / ISS deliverables. Selected CROs and vendors, negotiated contracts, led governance meetings, escalated issues, and resolved conflicts. Show less

• 

  Roivant Sciences

  Jan 2018 - Jan 2020

  Head of Program Management and Clinical Operations

  Program management leader for a cross-functional team of R&D experts across a broad portfolio of therapeutic areas to assess scientific platform value and develop integrated drug development strategies for potential acquisitions and internal assets. As a clinical operations leader, contributed to internal technology initiatives, established strategic CRO partnerships and successfully lead clinical studies as needed.

• 

  Sumitovant Biopharma, Inc.

  Jan 2019 - Jan 2023

  SVP/ VP, Head of Operations and Portfolio Management

  Led R&D portfolio management to maximize pipeline performance. Drove asset diligence processes, R&D integrated drug development strategies, program management, clinical operations, and corporate initiatives.Transferred from Roivant to Sumitovant after establishment of new company and worked for both companies for one year during transition period.

• 

  Life Sciences iSEAc

  Jan 2021 - now

  Founder

  Provides fractional Chief Operating Officer & executive leadership advisory services to biotech and digital health technology companies.Chief Operating Officer:• 4M Therapeutics: 2023 - Present• Melt Biosciences: 2024 - PresentExecutive Leadership Advisory: • Diasome: 2024 - Present• Lokavant: 2021 - 2024• PharmStars: 2023 - 2024